Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Asset ManagementConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Financial Services FeesIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest Expense - Fed FundsInterest ExpensesInterest Income - Debt SecuritiesInterest Income - NetInterest Income - TotalInterest income - LoansInvestment Gain (Loss)Net Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOther Non-Interest IncomeOther Operating ExpensesOther interest incomePreferred Dividend PaymentsProfit After TaxProvisionsRent ExpenseResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTrading IncomeWages, Salaries and Other
Others
Ratios

Morgan Stanley (MS-PQ) Research & Development (2016 - 2025)

Historic Research & Development for Morgan Stanley (MS-PQ) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Morgan Stanley's Research & Development rose 738.96% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year increase of 749.5%. This contributed to the annual value of $4.1 billion for FY2024, which is 829.14% up from last year.
  • Latest data reveals that Morgan Stanley reported Research & Development of $1.1 billion as of Q3 2025, which was up 738.96% from $1.1 billion recorded in Q2 2025.
  • Morgan Stanley's 5-year Research & Development high stood at $1.1 billion for Q3 2025, and its period low was $733.0 million during Q1 2021.
  • Over the past 5 years, Morgan Stanley's median Research & Development value was $933.0 million (recorded in 2022), while the average stood at $933.3 million.
  • As far as peak fluctuations go, Morgan Stanley's Research & Development surged by 3019.54% in 2021, and later soared by 578.78% in 2023.
  • Morgan Stanley's Research & Development (Quarter) stood at $833.0 million in 2021, then grew by 12.0% to $933.0 million in 2022, then grew by 5.79% to $987.0 million in 2023, then grew by 7.29% to $1.1 billion in 2024, then increased by 5.67% to $1.1 billion in 2025.
  • Its Research & Development stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.0 billion for Q1 2025.